IRST-IRCCS is a multispeciality cancer institute, founded in 2007, for the treatment of solid and haematological tumors through high-complexity clinical specialities: radiometabolic therapy, high-precision radiotherapy, cellular therapies and immunotherapy.

Research is one of the fundamental pillars of IRST - IRCCS and focuses on basic science, translational and clinical research and personalized risk assessment.

The aim of IRST – IRCCS is to strengthen the link between treatment and research, guaranteeing quality, originality, innovation and transferability of laboratory results to clinical practice.

IRST – IRCCS is situated in Meldola (Emilia Romagna - Italy), covering an area of over 1.1 million inhabitants and is fully integrated with National Health Service.